![]() | |
Clinical data | |
---|---|
Trade names | Intracef, Velocef |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601206 |
Routes of administration | Oral,IM,IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Well absorbed |
Protein binding | <10% |
Metabolism | Nil |
Eliminationhalf-life | 0.9 hours |
Excretion | Renal, unchanged |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.049.199![]() |
Chemical and physical data | |
Formula | C16H19N3O4S |
Molar mass | 349.41 g·mol−1 |
3D model (JSmol) | |
Melting point | 140 to 142 °C (284 to 288 °F) (dec.) |
| |
| |
(verify) |
Cefradine (INN) orcephradine (BAN) is a first generationcephalosporinantibiotic.[1]
Cefradine is distributed in the form of capsules containing 250 mg or 500 mg, as a syrup containing 250 mg/5 ml, or in vials for injection containing 500 mg or 1 g.[citation needed]
It is not approved by the FDA for use in the United States.[citation needed]
Birch reduction of D-α-phenylglycine led to diene (2). This was N-protected usingtert-butoxycarbonylazide and activated for amide formation via the mixed anhydride method using isobutylchloroformate to give3. Mixed anhydride3 reacted readily with 7-aminodesacetoxycephalosporanic acid to give, after deblocking, cephradine (5).
The antibiotic is produced under many brand names across the world.[5]